Cita APA

Dockery, L., Gunderson, C., & Moore, K. (2017). Rucaparib: The past, present, and future of a newly approved PARP inhibitor for ovarian cancer. Onco Targets Ther.

Citación estilo Chicago

Dockery, LE, CC Gunderson, and KN Moore. "Rucaparib: The Past, Present, and Future of a Newly Approved PARP Inhibitor for Ovarian Cancer." Onco Targets Ther 2017.

Cita MLA

Dockery, LE, CC Gunderson, and KN Moore. "Rucaparib: The Past, Present, and Future of a Newly Approved PARP Inhibitor for Ovarian Cancer." Onco Targets Ther 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.